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We study if foreign aid received in the past towards Development and towards the Health 
sector helped developing countries response to COVID-19, using the number of Cases and Deaths 
of COVID-19 as outcome variables. We find statistically significant evidence that both types of 
funding have a positive relationship with the number of Cases and Deaths of COVID-19 registered. 
This result may indicate that countries that receive more funding are also the ones in worse health 
and development conditions to begin with, and even when receiving higher disbursements, they 
remain less prepared to fight COVID-19. Because we lack a control for number of tests conducted 
for COVID-19, another hypothesis is that countries that receive more funding were able to run 
more tests for COVID-19, resulting in higher records of cases and deaths from the virus. 
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Pandemics are major drains on a country’s economy and life and the COVID-19 pandemic 
is in no way different. So far, COVID-19 has infected over 43.6 million people in the world and 
over 28.2 million in underdeveloped countries alone1. 
With talks of new vaccination for the COVID-19 virus, the pandemic will soon be a 
problem of the past for most developed nations, but it may keep affecting more debilitated countries 
– with low hand hygiene customs and bad respiratory etiquette along with poor health conditions 
–  for a lot more time, adding to the burden caused by other major epidemics, as is the case of HIV 
and Ebola. 
To try to stop the spread of COVID-19, developed economies have adopted internal 
measures focusing firstly on the pressure of COVID-19 on their own health care systems before 
turning to the billions of people in developing nations, that are getting less support than they would 
if this was an emergency affecting exclusively the developing world, broadening the gap between 
the third world and the developed nations. 
The goal of the analysis is to study if the past disbursement of Development funding and 
Health specific funding has had an impact on countries’ response to COVID-19, specifically if it 
has an impact on the number of Cases and Deaths from COVID-19 reported in countries on the 
International Monetary Fund (IMF) Emerging Markets and Developing Economies list.  
We use OECD datasets to collect data on Development and Health funding. Development 
funding per capita is the total sum of disbursements received as Official Development Assistance 
(ODA), Other Official Flows (OOF) or other monetary aid provided towards development from 
 
1 Between the 1st of January until the 27th of October. Numbers taken from the EU Open Data Portal, considering a 
country as underdeveloped if it is included in the FMI’s Emerging Markets and Developing Economies list. 
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2009 to 2018, in Millions USD, divided by each country’s total population2. Heath funding per 
capita is the sum of international payments made towards strengthen the health sector of each 
country from 2009 until 2010, in Millions of USD, divided by the total population of each country. 
The mechanism through which we expect Development and Health funding to have an 
impact in lowering the number of people infected with COVID-19, and the number of people that 
die with the virus, is by better preparing health systems to receive patients with COVID-19. Mainly 
by allowing for better health infrastructures, as ventilators, hospital beds and qualified health 
workers, but also by allowing the population to have access to running potable water, suitable 
sanitation, and respiratory masks. It is expected that this mechanism is more effective in lowering 
the number of deaths than cases from COVID-19, since the number of cases of COVID-19 is more 
dependent on day to day behavior than on the quality of each country’s health system.  
The results found show that although funding towards the Health sector from 2009 to 2010 
has no statistically significant power to explain the number of COVID-19 Deaths per capita 
registered, the disbursements made towards Development from 2009 to 2018 have consistently 
statistically significant positive coefficients. To put in words, the data shows that countries that 
have received one Million USD of additional Development funding per capita from 2009 until 
2018 have registered higher number of deaths from COVID-19 per capita, ranging from 0.00062 
to 0.00158, on average, ceteris paribus, giving signs of lower resilience towards the COVID-19 
pandemic.  
For the results of the impact on number of Cases from COVID-19 per capita, both 
Development and Health specific funding show statistically significant positive coefficients, again 
 
2 Data from the World Bank. 
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displaying that higher disbursements made towards Development and the Health sector result in 
higher records of Cases from COVID-19 per capita. 
2. Literature Review 
The research question proposed falls in three different categories: effects of foreign aid 
towards development, impact of foreign aid disbursed towards the health sector and COVID-19 
influence on the developing world. 
The study of the effects of foreign aid is wide-ranging. From its role on economic growth 
and on reconstruction of countries in post-war periods, to its impact on the promotion of political 
and social stability and on overall health, various research is available where two different 
hypotheses are in question. On one side, authors believe that foreign aid has the power to promote 
development and economic growth – Burnside, Craig, and Dollar (2000) use a World Bank dataset 
to show that aid influences growth of income when conditioned on good policies, and that this 
impact is stronger on government consumption than on economic growth. Rajan and Subramanian 
(2008) show no evidence that aid is more effective with good policies but report a small positive 
relationship between aid inflows and economic growth. On the other side, some researchers argue 
that foreign aid not only does not increase development but also demotes upcoming economic, 
democratic and development growth, much like a natural resource curse, a foreign aid curse is 
proposed – Subrahmanian (1973), Harford and Klein (2005) and Djankov, Montalvo and Reynal-
Querol (2008) all contribute to the literature on this argument.  
These two different hypotheses also apply when talking about the impact of health specific 
funding, with different research achieving different outcomes. Williamson (2008), for example, 
showed that foreign aid disbursed specifically towards the health sector is unsuccessful in 
promoting both economic and human development and does not show significant evidence of 
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raising general health. Gyimah-Brempong (2015) reveals the opposite, aid disbursed specific 
towards the health sector has a statistically significant positive result on health expenditures in 
Africa and is successful in increasing overall health in the continent.  
Specifically on the effects of foreign aid in increasing developing countries’ response to 
pandemics, Kavanagh et al. (2019) study the effects of US foreign policy on ending epidemics, 
such as HIV, Malaria and Tuberculosis and find that there is statistically significant evidence that 
U.S. political and financial help  “could help reduce the pandemics […], while preventing 
tomorrow’s outbreaks from becoming global health emergencies” (Kavanagh et al. 2019, 51). 
Oppenheim and Yamey (2017) also suggest that increasing financial disbursements towards public 
healthcare systems to Low- and Middle-Income Countries (LMIC) could increase these countries’ 
preparedness to face pandemics. 
Although the study of the effects of development and health specific funding is extensive, 
as described above, research on the effects of COVID-19, and especially its effects on developing 
countries is still quite virgin.  Miller (2020) takes a sample of West African countries to describe 
the lessons learned from Ebola that can be used to fight COVID-19, writing that “structural 
healthcare deficiencies  […] and limited testing infrastructure and supplies, as well as the potential 
need to isolate large segments of the population in a region that is so heavily reliant on informal 
economic and social structures” are one of the biggest challenges for these countries.  
The IMF’s Finance and Development issue of June 2020 focuses on Policies, Politics and 
Pandemics. Here, Sayeh and Chami (2020) raise awareness towards the negative income shock in 
developing countries during the COVID-19 pandemic, caused by a decrease in remittances, that 
amplify the negative economic shock already in place due to Coronavirus constrains. This negative 
income shock in remittances might lead to a rise in migrants returning to their home countries, 
which in turn may escalate the spread of the virus in the future. 
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On a final note, Alwazir (2020) writes for the United Nation’s Office of the High 
Representative for the Least Developed Countries, Landlocked Developing Countries and Small 
Island Developing States, affirming that the COVID-19 pandemic has the power to devastate under 
developed countries, “critically dependent on imported medical and pharmaceutical products” that 
are even more vulnerable than others since they face not only a major health crisis – with increasing 
numbers of cases and deaths from COVID-19 –, but a great economic and financial crisis as 
commodity prices decrease due to Coronavirus restrictions across the world. 
Looking at our main hypothesis, the literature available highlights the importance of 
conducting more research on the impacts of foreign aid in controlling pandemics. With different 
hypothesis on the table we are left uncertain of the behavior that Development and Health specific 
funding have in improving countries resilience to COVID-19. 
3. Data 
We use data on the number of Deaths and Cases from COVID-19 reported by the EU Open 
Data Portal, aggregated in weekly intervals, for the period between the 1st of January 2020 until 
the 27th of October 2020, for a total of 43 even weeks. We compare this dataset with the data 
reported by the University of Oxford, which showed a correlation of 0.91 on Cases from COVID-
19 and 0.68 for the data on Deaths from COVID-19. We divide both Cases and Deaths from 
COVID-19 by the total population to generate outcome variables per capita that take into 
consideration the size of the country when measuring the impact of COVID-19. 
To the EU Open Data Portal dataset, we add the variables Statistical Anomaly Cases and 
Statistical Anomaly Deaths that take the value of 1 when a week shows a total negative value for 
either number of cases or deaths, respectively, and 0 otherwise. The negative values of cases and 
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deaths from COVID-19 in the dataset reflect revisions made a posteriori to the data. These 
variables are then used to check if these statistical anomalies have an impact on the results found. 
For the variables of interest, Development Funding per capita and Health Funding per 
capita, we use data from the OECD dataset to get, respectively, the sum of overall disbursements 
to each country in analysis from 2009 to 2018, divided by the total population of each country; and 
the sum of international payments made towards the health sector of each country from 2009 until 
2010, in Millions of USD, divided by each county’s total population. We use Development and 
Health Funding per capita to reflect the relevance of Funding in the needs of the country, proxied 
by population. 
It is to be noted that the time frame used for the disbursements of Health specific funding 
is of only two years (2009 and 2010) due to the low amount of data available. Contrary to what is 
found with Development funding, where the variable shows the cumulative of various years, the 
data on Health specific funding is short and so, fails to reflect differences that might have occurred 
in the disbursement of Health funding through the years in different countries. 
As control variables we use data on life expectancy at birth from the World Health 
Organization (WHO) as a proxy for the health system quality in each country, and data obtained 
from the Oxford COVID-19 Government Response Tracker (OxCGRT) on the social restrictions 
applied to each country’s population to prevent the spread of COVID-19. From the latter, we use 
data on the maximum restriction level applied each week in our analysis for schools closing, 
workplace closing and stay at home requirements (ranging from 0 – no measures – to a maximum 
of 3), cancelation of public events, restrictions on international movements, closing of public 
transportation and record of public information campaigns on COVID-19 awareness (reaching 
from 0 – no measures applied – to a maximum of 2) and restrictions on gatherings and international 
travel controls (going from 0 to a maximum of 4).  
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On top of the control variables already mentioned we try to add the percentage of elderly 
population to control for the higher vulnerability from COVID-19 on older demographic groups, 
but this variable was too correlated with the Life Expectancy at Birth (0.91), our proxy for Health 
system quality, to show true results.  
We focus the analysis to developing countries in the IMF Emerging Markets and 
Developing Economies list, which counts a total of 146 countries3.  
Basing our choice for the determinants of aid in the results found in Alesina and Dollar 
(2000) we build a dataset for Years as a Dependent Territory from 1900 to 2000, with records from 
the Central Intelligence Agency, the Our World in Data and the UN list of Non self-governing 
territories as a proxy for years as a colony. We also use a Trade Openness Index that shows the 
ratio of exports and imports to GDP in 2007, the Size of the Country (Total Population), the GDP 
per capita in 2007 – as a proxy for poverty –, a measure of Political Regime in 2014 that goes from 
-10 (full autocracy) to 10 (full democracy), measures for the Rule of Law in 2007, Political Stability 
in 2008, Government Effectiveness in 2008 and Corruption score in 2008 (all ranging from -2.5 to 
2.5) and a Human Rights score for 2007 as explanatory variables for the disbursements of 
Development Funding from 2009 to 2018 and the Health Funding received from 2009 to 2010. 
The correlation of Development funding per capita and Health funding per capita with the 
variables described above is shown in Tables 7 and 8, respectively.  
Focusing first on Table 7, for the correlations with Development funding per capita, there 
are strong positive relationships with Human Rights score (0.54), Trade openness Index (0.44), 
Rule of Law (0.43), Corruption score (0.43), Government Effectiveness (0.38), Political Stability 
(0.36), Political Regime (0.32) and with GDP per capita (0.22). These results suggest that, as found 
 
3 We considered using the UN’s list of Least Developed Countries as the focus of our analysis, but this is a rather 
restrictive group that would reduce the scope of our results. 
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in Alesina and Dollar (2000), “foreign aid flows respond to political variables”. Richer more 
developed countries – where the Government is more effective and stable, human rights are 
followed and the economy is more open – receive higher Development funding per capita.  
Total Population has a negative relationship with the total disbursement of Development 
funding per capita from 2009 to 2018 (-0.19) showing that bigger countries receive less per capita. 
Contrasting to the results found in Alesina and Dollar (2000), our proxy for colonial past – 
Years as a Dependent Territory in the 20th century – shows no statistically significant relationship 
with the total Development funding received per capita between 2009 and 2018 (-0.02). 
Turning to Table 8, for the correlations with Health funding per capita, the results indicate 
that the strongest relationship is with the Years as a Dependent Territory in the 20th century (0.31), 
going along with the results found in Alesina and Dollar (2000) for the impact of colonial past in 
the disbursement of foreign aid. Likewise, most political variables show – as they did for 
Development Funding per capita – a strong positive relationship with Health funding per capita, as 
is the case of Human Rights score (0.30), Political Stability (0.26), the control for Corruption 
(0.24), Trade Openness index (0.18) and Rule of Law (0.11). Indicating, once again, that countries 
that are more politically stable, more democratic and for which the economy is more open, receive 
more Health funding per capita. In contrast with the results from Table 7, the Government 
Effectiveness score has no statistically significant relationship with the disbursement of Health 
specific aid from 2009 to 2010 (0.01).  
There is a strong negative relationship of Health Funding per capita with Total Population 
(-0.16), larger countries also receive less in Health specific funding per capita, and with GDP per 
capita (-0.15). The latter suggesting that richer countries receive less Health specific funding per 
capita, perhaps because they can make higher internal investments towards the Health sector, 
reducing their need for support from the international community. 
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The correlations described above are extremely similar to the ones found when we include 
only countries that are on the IMF’s Emerging Markets and Developing Economies list, as seen in 
Tables 9 and 10, for the correlations with Development funding per capita and health Funding per 
capita, respectively.  
4. Methodology 
We start with an OLS regression to model the impact of Development and Health funding 
on the number of Cases and Deaths from COVID-19, using different outcome variables such as the 
Weekly total number of Cases and Deaths from COVID-19, the Number of Cases and Deaths per 
capita on the first wave of COVID-19 in each country – determined by the period from the first 
case of COVID-19 until the second week in a row of negative growth of cases from COVID-19 in 
each country – and the Average growth of COVID-19 cases and deaths.  
As control variables we use two cross terms to measure the evolution of the Pandemic – 
represented by the added Development funding received by each country from 2009 to 2018 times 
the week number in analysis, and the added Health funding received in 2009 and 2010 times the 
week number in our analysis –, a measure of the Health System quality –  Life Expectancy at Birth 
–, and the maximum weekly restriction level applied to schools closing, workplaces closing, 
cancelations of public events, restrictions applied on gatherings, closing of  public transportations, 
stay at home requirements, restrictions on international move, international travel controls and 
public information campaigns on COVID-19 awareness. 
The results found in the OLS analysis are compromised due to endogeneity from 
simultaneity in the model: Countries that receive more Development funding and Health specific 
funding are in most cases poorer, least developed countries. On one hand, populations in the 
developing world “often live in crowded, multigenerational households”, where it lacks “ready 
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access to running water” and “adequate sanitation”. On the other hand, there are less opportunities 
to apply restrictions to avoid the spread of the viruses, like working from home or schools closing, 
due to “poor or no internet connection […] at home”4.  
Hence, countries that receive more Development funding and Health specific funding are 
also the ones more vulnerable to the spread of COVID-19. The variables of interest and the outcome 
variables are jointly determined influencing each other at the same time. Endogeneity is also proven 
with a Durbin test and a Wu-Hausman test for Endogeneity, consistently rejecting the null 
hypothesis that all variables are exogenous.  
To solve the endogeneity problem, we take the results found in Alesina and Dollar (2000) 
for the pattern of allocation of foreign aid, to run a Second Stage Least Square (2SLS) analysis.  
In the first stage of our model we use cross section analysis on political and economic 
variables – Total population, Trade Openness index, GDP per capita, measures of Rule of Law, 
Political Stability, Government Effectiveness, Corruption and Human Rights score – along with 
the number of years as a dependent state from 1900 to 2000 (as a proxy for the colonial past of the 
country) to justify the amount of Development funding per capita and Health funding per capita 
received by each country. These variables are uncorrelated with the number of COVID-19 cases 
and deaths but highly correlated with the allocation of foreign aid, as described in section 3. 
We do not include, in the determinants of aid, the variable for Years as a non-dependent 
state from 1900 to 2000, when explaining the overall Development funding per capita received 
from 2009 to 2018, and the Government Effectiveness index, when determining the total Health 
specific funding per capita from 2009 to 2010, since these variables are not statistically 
significantly correlated with the disbursement of funding, as stated in the previous section.   
 
4 From the Commentary on COVID-19 Challenges in Developing Countries by Mathew E Levison, MD, Adjunct 
Professor of Medicine, Drexel University College of Medicine 
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In the second stage equation we use only control variables specific to the spread of 
Coronavirus and to control for the natural evolution of the pandemic – restrictions applied to avoid 
the spread of the viruses, week of analysis to control for the natural evolution of the pandemic and 
a proxy for the health system quality.  
We limit our sample exclusively to countries on the IMF’s list of Emerging Markets and 
Developing Economies (as a representation of the underdeveloped world) and opening the sample 
to all countries in the world for which there were records on the COVID-19 EU Open Data Portal 
dataset; by jointly determining Development Funding and Health Funding in the first stage 
equation and by analyzing the impact on COVID-19 cases and deaths of each type of funding 
individually – either towards Development or Health. The results are described in the following 
section. 
5. Results 
We start with several regressions using Deaths per capita as the outcome variable. The full 
results are described in Tables 1 to 3 in the Appendix. Table 11, bellow, shows the results of these 
analysis for the variables of interest only. Columns 1 and 2 present the results when determining 
Development funding and Heath specific funding together on the first stage, for all countries in the 
world for which there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset 
(column 1) and when only including countries that are on the IMF Emerging Markets and 
Developing Economies list in the analysis (column 2). Columns 3 and 4 show the results when 
determining Development funding alone on the first stage. Again, for all countries in the world for 
which there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset (column 
3) and by only including countries that are on the IMF Emerging Markets and Developing 
Economies list in the analysis (column 4). Columns 5 and 6 show the results when determining 
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Health funding alone in the first stage equation, for all countries in the EU Open Data Portal dataset 
(column 5) and only for countries in the IMF Emerging Markets and Developing Economies list 
(column 6). 
The results of these analysis show that although Health specific funding received from 2009 
to 2010 has no statistically significant power to explain changes in the number of Deaths per capita 
from COVID-19, funding received towards Development is always statistically significant either 
at the 5% significance level (when Development and Health funding are determined together in the 
first phase) or at the 10% significance level (when Development funding is determined alone in the 
first phase).  
 
Table 11. 2SLS estimation: Dependent variable: Deaths from COVID-19 per capita from 1st of January until 27th of October 
2020. 
Deaths per capita 
  (1) (2) (3) (4) (5) (6)  



































Funding per capita 
(2009-2018) 
.0015758*** .0011393** .0006511* .0006224*   
   (.0005802) (.0005747) (.0003677) (.0003675)   
 Health Funding 
per capita (2009-
2010) 
-.0259904 -.001651   .0085749 .0191244 
   (.0210221) (.020848)   (.015014) (.0150281) 
 Observations 3678 3602 3773 3697 3821 3745 
 R-squared .1460325 .1549788 .1510264 .1577045 .151115 .157373 
Standard errors are in parentheses 





The results show that countries that received one million USD more in Development 
specific funding per capita from 2009 to 2018 had higher registered number of Deaths per capita 
from COVID-19, ranging anywhere from 0.00062 to 0.00158 on average, ceteris paribus. This 
means that if a country with 10 Million people received 1 million USD more per capita towards 
Development from 2009 to 2018 it would have registered anywhere from 6,224 to 15,758 more 
Deaths from COVID-19 for the period of 1st of January until de 27th of October 2020, on average, 
ceteris paribus.  
Table 12 shows the results for the variables of interest – Development funding per capita 
received from 2009 until 2018 and Health funding per capita received from 2009 to 2010 – when 
using number of Cases per capita from COVID-19 as the outcome variable. Complete results are 
presented in Tables 4 to 6 in the Appendix. 
Like in Table 11, columns 1 and 2 present the results when determining Development 
funding and Heath specific funding together on the first stage, columns 3 and 4 show the results 
when determining Development funding alone on the first stage and columns 5 and 6 show the 
results when determining Health funding alone in the first stage equation, for all countries in the 
world for which there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset 
– columns 1, 3 and 5 – and when only including countries that are on the IMF Emerging Markets 
and Developing Economies list in the analysis – columns 2, 4 and 6.  
The results presented in Table 12, show, once again, that Development funding received 
from 2009 to 2018 has a statistically significant (at the 5% significance level) positive impact on 
the number of Cases per capita from COVID-19, ranging from 0.079 to 0.107, ceteris paribus. 
Using again the example of a country with 10 Million people, these results show that receiving 
one Million USD more per capita in Development funding from 2009 to 2018 results in 793,981 





Table 12. 2SLS estimation: Dependent variable: Cases from COVID-19 per capita from 1st of January until 27th of October 
2020. 
Cases per capita 
   
In terms of Health specific Funding, when determined alone in the first stage equation, we 
have significant evidence – at the 5% level – that receiving 1 Million USD more per capita in 
Health funding from 2009 to 2010 increased the number of Cases of COVID-19 registered from 
the 1st of January until the 27th of October 2020 from 1.307 to 1.539 per capita, on average, ceteris 
paribus. If we imagine a country with 10 Million people, this means that receiving 1 Million USD 
more per capita increased the number of cases of COVID-19 registered anywhere from 13 Million 
to 15 Million.  
Because the coefficient for Health funding is negative in column 1 – significant at the 10% 
significance level – together with the higher, positive coefficient for Development funding per 




















    
















 Development Funding per capita 
(2009-2018) 
.1066287*** .0918926*** .0815058*** .0793981***   
   (.0164025) (.0161293) (.0104477) (.0104189)   
 Health Funding per capita (2009-
2010) 
-1.0891337* -.3910457   1.3065337*** 1.5388425*** 
   (.5942858) (.5850838)   (.4349815) (.4341822) 
 Observations 3678 3602 3773 3697 3821 3745 
 R-squared .2100268 .2284439 .2414437 .24975 .2186429 .227631 
Standard errors are in parentheses 




capita, we suspect of possible omitted variable bias, where Health funding is capturing the effect 
of other omitted variables, in particular, the effect of Development funding. The correlation 
between the two variables is 0.11. 
The results of the analysis are surprising, as it would be expected that countries that receive 
more funding either towards Development or Health would be able to invest more in important 
infrastructure to fight COVID-19 – ventilators, higher numbers of health workers, sanitary and 
hygiene solutions, etc. – that would result in lower number of Deaths and Cases from COVID-19. 
But the results show exactly the opposite, countries that receive more funding (towards 
Development and the Health sector) seem to have registered more Cases and Deaths from COVID-
19 than others. One hypothesis to explain the negative impacts of Development funding received 
from 2009 until 2018, and Health funding received from 2009 to 2010 on countries’ response to 
COVID-19 is that countries that receive more funding were able to invest more in infrastructure 
to test for COVID-19, hence having higher records of detected Deaths and Cases from COVID-19 
than other countries that have received less funding, this does not necessarily mean that countries 
that received higher disbursements of foreign aid have higher real Cases and Deaths from COVID-
19, since we do not know the real number of infected people due to lack of testing infrastructure 
(this is something we cannot control for since there are no datasets available with records of tests 
conducted for COVID-19 for the entire world). Another hypothesis is that the countries that receive 
higher disbursements of Development and Health specific funding are also the ones with worse 
health systems (which our control “Life Expectancy at Birth” fails to fully capture) and least 
developed, with worst life conditions (we do not include any control for the starting point in terms 
of development) and so, even when receiving more funding these countries remain behind others 
in terms of health system quality and development status, performing worse in number of Cases 
and Deaths from COVID-19.  
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For the control variables we find statistically significant evidence – at the 1% significance level 
– that the number of cases and deaths per capita of COVID-19 increased with the number of weeks of 
analysis, showing the natural evolution of the pandemic. This effect is stronger when the outcome 
variable used is the number of Cases per capita from COVID-19. That is, although both Cases and 
Deaths per capita from COVID-19 have increased along the year with the spread of the virus across 
the globe, the number of cases per capita has had a more pronounced growth than the number of deaths 
per capita. It is to be noted for further research that since the evolution of COVID-19 was not linear – 
there were times of intensive growth of the number of Cases and Deaths of COVID-19 followed by 
periods of low records of number of Cases and Deaths of COVID-19 – this variable would have 
reflected better the evolution of the pandemic if used in a polynomial of degree 3 or 4.  
The coefficient for the variable Life Expectancy at Birth, our control for the health system quality 
and a proxy for the size of the elderly population in each country, is consistently positive and significant 
at the 1% level. These results can be interpreted in two ways. On one hand, having a longer life 
expectancy at birth means having a larger elderly population, which is one of the most at risk population 
group for COVID-19, resulting in higher number of cases and deaths per capita registered from 
COVID-19. On the other hand, the results of the analysis might be misleading due to not including a 
control for the number of tests conducted, so countries that have a better health care system might be 
able to conduct more tests for COVID-19, hence resulting in a higher number of detected cases of 
Coronavirus recorded, which can explain the higher coefficients when using Cases of COVID-19 per 
capita as the outcome variable.  
For the control variables on the restrictions applied in each country, Schools closing, 
Restrictions on gatherings and Closing public transports have consistently significant positive 
coefficients at the 1% significance level. On one hand, these results may indicate that these 
restrictions are not only not successful in lowering the number of Cases and Deaths per capita from 
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COVID-19 but also increase the spread of the virus. On the other hand, these positive relationships 
may demonstrate an endogeneity problem, since, closing public transports and restrictions on 
schools closing and on gatherings are only applied when the growth of cases of COVID-19 is very 
high and they take a while to produce significant effects.  
Public information campaigns to raise awareness on the dangers of Coronavirus are 
consistently successful in decreasing the number of Cases and Deaths of COVID-19 per capita at 
the 1% significance level, ceteris paribus. Our control for Workplaces closing, although negative 
and statistically significant throughout the analysis (closing work places, and opting to work from 
home instead, is effective in decreasing the number of cases and deaths per capita of COVID-19) 
it shows a statistically not significant coefficient when using Cases of COVID-19 per capita as our 
outcome variable and determining Health specific funding alone in the first stage equation.  
 On another note, Cancelation of public events, Stay at home requirements and Restrictions 
on international move are always statistically not significant (at the 5% level) in explaining changes 
in number of Deaths and Cases of COVID-19 per capita.  
The variable International travel controls is also statistically unsignificant when using Cases 
from COVID-19 per capita as our outcome variable. When using Deaths from COVID-19 per 
capita as our outcome variable, although the coefficient for International travel controls shows a 
negative sign when including the entire world in the analysis – statistically significant at the 5% 
level –, when limiting the sample to countries on the IMF Emerging Markets and Developing 
Economies list and excluding statistical anomalies from the analysis the coefficient is never 
statistically significant. 
Lastly, from the analysis on the impact of the negative values of Cases and Deaths per 
capita from COVID-19 in the dataset – that reflect revisions made a posteriori to the data – the 
data shows almost no statistically significant changes in the results found by either excluding or 
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including these statistical anomalies. The results from this analysis are shown in in columns 2 and 
4 of Tables 1 to 6. 
6. Conclusion 
We use Two Stage Least Squares analysis to understand if the total disbursements of 
Development funding per capita from 2009 to 2018 (10 years) and Health specific funding from 
2009 to 2010 (2 years) per capita helped developing countries response to COVID-19. Specifically, 
we study if they had an impact in reducing the number of Cases and Deaths from COVID-19 per 
capita in countries on the IMF Emerging Markets and Developing Economies list. 
The results, after adjusting for possible bias that poorer countries are also the ones more 
vulnerable to the spread and negative impacts of COVID-19, show positive coefficients for both 
Development funding received from 2009 to 2018 and Health Funding received from 2009 to 2010 
on the registered number of Cases and Deaths per capita from COVID-19. That is, receiving more 
Development or Health funding in the past has hurt countries’ response to COVID-19, registering 
more Cases and Deaths from the virus. 
It is important to be noted that the results found in this analysis are dependent on the data 
available, which by the recency of the events is little and still to be reviewed by scholars. We know 
that the real number of cases and deaths from COVID-19 around the world is underestimated, 
especially in rural areas of the underdeveloped world where a lot of cases from COVID-19 are not 
detected due to absence of appropriate resources. We also know that different countries have 
different ways of registering Cases and Deaths from COVID-19 for which there is no way to control 
for. For example, in Portugal until June 2020 if someone died in a car accident but tested positive 
for COVID-19 it would be officially registered as a death with COVID-19. These temporal and 
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geographical differences in registering the number of Cases and Deaths from COVID-19 need to 
be controlled for, using an appropriate dataset which is not yet available.  
There is a lot of further research that can be done on the topic of foreign aid’s relationship 
with the spread of COVID-19, but to support additional research, a lot more data needs to be 
collected on this topic. Namely, extra research could take advantage of data on number of tests 
conducted for COVID-19 – to control for the fact that richer countries, that are capable of running 
more tests will also be the ones registering more cases – and a dataset for the quality of laboratory 
and clinical systems for each country of the world, to control for the fact that different countries 
have different ways of recording Cases and Deaths from COVID-19.  
Further research could also analyze the pressure COVID-19 imposed on Health systems 
across the world by considering other outcome variables such as deaths from other diseases due to 
Health System capacity issues. Likewise, additional research could focus on economic outcome 
variables to measure each country’s response to COVID-19, for example the impact of 
Development funding and Health specific funding on unemployment, famines and GDP growth 
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Appendix A. List of all variables, their definition, source and basic summary statistics.  
 




Number of weekly 
Cases of COVID-19 
divided by the total 









Number of weekly 
Deaths of COVID-19 
divided by the total 













2009 to 2019 




Total sum of 
disbursements 
received towards the 
health sector from 
2009 to 2010 
OECD 0,00001480 0,00002020 0,00000005 0,00012800 
Weeks 
Number of the week 
in analysis from the 
1st of January 2020 
until the 27th of 
October 2020 (total of 
43 even weeks) 




Life Expectancy at 
birth 





ranging from 0 (no 
measures) to a 











ranging from 0 (no 
measures) to a 






1,26389800 1,11357600 0 3 
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ranging from 0 (no 
measures) to a 












ranging from 0 (no 
measures) to a 













ranging from 0 (no 
measures) to a 













ranging from 0 (no 
measures) to a 














ranging from 0 (no 
measures) to a 











ranging from 0 (no 
measures) to a 












ranging from 0 (no 
measures) to a 






2,47954200 1,50028500 0 4 
Years as a 
dependent 
territory from 
1900 to 2000 
Number of years as a 
dependent, non self-
governing territory 













36,51672000 0 100 
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Table 1. Regression results of 2SLS regression analysis with Deaths from COVID-19 per capita 
as the outcome variable and Development Funding and Health specific Funding determined 
together in the first stage. The table presents results for all countries in the world for which there 
was data on COVID-19 deaths and cases in the EU Open Data Portal dataset (1), results for all 
countries in the world for which there was data on COVID-19 deaths and cases in the EU Open 
Data Portal dataset excluding from the analysis weeks with negative records of deaths from 
COVID-19 (2), results for countries in the IMF Emerging Markets and Developing Economies 
list (3) and results for countries in the IMF Emerging Markets and Developing Economies list 






Ratio of exports and 







55,98170000 1,95974300 398,7458 









Product divided by 




16690,23 25060,49 225,86 170534,70 
Political 
Regime 
Political Regime in 
2014 ranging from -
10 (full autocracy) to 




4,19398 6,07933 -10 10 
Rule of Law  
Measure for the Rule 
of Law in 2007 






1,02613800 -2,40595500 2,01373000 
Political 
Stability 
Political Stability in 
2008 ranging from -









Effectiveness in 2008 




0,01137840 1,00615600 -2,40219500 2,43697500 
Corruption 
Corruption score in 
2008 ranging from -





1,01511400 -1,86871400 2,39306400 
Human 
Rights 
Human Rights score 








Deaths per capita. Development and Health funding determined together in the first stage 
      (1)   (2)   (3)   (4) 













Development Funding per capita .0015758*** .0016377*** .0011393** .0012081** 
   (.0005802) (.0005745) (.0005747) (.0005688) 
 Health Funding per capita -.0259904 -.0282817 -.001651 -.0040383 
   (.0210221) (.0208161) (.020848) (.020634) 
 Week 2.000e-07*** 2.000e-07*** 2.000e-07*** 2.000e-07*** 
   (0) (0) (0) (0) 
 Schools closing 1.100e-06*** 1.100e-06*** 1.100e-06*** 1.100e-06*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Workplace closing -7.000e-07*** -7.000e-07*** -7.000e-07*** -7.000e-07*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Cancelation public events 4.000e-07 4.000e-07 4.000e-07 4.000e-07 
   (4.000e-07) (3.000e-07) (4.000e-07) (4.000e-07) 
 Restrictions on gatherings 5.000e-07*** 6.000e-07*** 5.000e-07*** 5.000e-07*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Close public transport 1.400e-06*** 1.400e-06*** 1.500e-06*** 1.500e-06*** 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 Stay at home requirements 1.000e-07 1.000e-07 -1.000e-07 -1.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Restrictions on International move 4.000e-07 4.000e-07 4.000e-07 4.000e-07 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 International travel controls -3.000e-07** -3.000e-07** -3.000e-07* -2.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Public Information Campaigns -2.400e-06*** -2.600e-06*** -2.400e-06*** -2.600e-06*** 
   (4.000e-07) (4.000e-07) (4.000e-07) (4.000e-07) 
 Life Expectancy at Birth 3.000e-07*** 3.000e-07*** 3.000e-07*** 3.000e-07*** 
   (0) (0) (0) (0) 
 Constant -.0000217*** -.0000214*** -.0000261*** -.0000258*** 
   (3.000e-06) (2.900e-06) (3.000e-06) (3.000e-06) 
 Observations 3678 3677 3602 3601 
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 R-squared .1460325 .1507923 .1549788 .1604072 
Standard errors are in parentheses 
*** p<.01, ** p<.05, * p<.1  
 
Table 2. Regression results of 2SLS regression analysis with Deaths from COVID-19 per capita 
as the outcome variable and by determining Development Funding alone in the first stage. The 
table presents results for all countries in the world for which there was data on COVID-19 deaths 
and cases in the EU Open Data Portal dataset (1), results for all countries in the world for which 
there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset excluding 
from the analysis weeks with negative records of deaths from COVID-19 (2), results for 
countries in the IMF Emerging Markets and Developing Economies list (3) and results for 
countries in the IMF Emerging Markets and Developing Economies list excluding from the 
analysis weeks with negative records of deaths from COVID-19 (4). 
 
Deaths per capita. Development funding determined alone in the first stage 
      (1)   (2)   (3)   (4) 
    
All countries 











 Development Funding per capita .0006511* .0006538* .0006224* .000625* 
   (.0003677) (.000364) (.0003675) (.0003638) 
 Week 2.000e-07*** 2.000e-07*** 2.000e-07*** 2.000e-07*** 
   (0) (0) (0) (0) 
 Schools closing 1.100e-06*** 1.200e-06*** 1.100e-06*** 1.100e-06*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Workplace closing -6.000e-07*** -6.000e-07*** -6.000e-07*** -7.000e-07*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Cancelation public events 4.000e-07 4.000e-07 4.000e-07 4.000e-07 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 Restrictions on gatherings 5.000e-07*** 5.000e-07*** 5.000e-07*** 5.000e-07*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Close public transport 1.300e-06*** 1.400e-06*** 1.400e-06*** 1.400e-06*** 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 Stay at home requirements -1.000e-07 -1.000e-07 -2.000e-07 -2.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Restrictions on International move 3.000e-07 3.000e-07 4.000e-07 4.000e-07* 
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Table 3. Regression results of 2SLS regression analysis with Deaths from COVID-19 per capita 
as the outcome variable and by determining Health specific Funding alone in the first stage. The 
table presents results for all countries in the world for which there was data on COVID-19 deaths 
and cases in the EU Open Data Portal dataset (1), results for all countries in the world for which 
there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset excluding 
from the analysis weeks with negative records of deaths from COVID-19 (2), results for 
countries in the IMF Emerging Markets and Developing Economies list (3) and results for 
countries in the IMF Emerging Markets and Developing Economies list excluding from the 
analysis weeks with negative records of deaths from COVID-19 (4). 
 
Deaths per capita. Development funding determined alone in the first stage 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 International travel controls -3.000e-07** -3.000e-07* -3.000e-07* -2.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Public Information Campaigns -2.300e-06*** -2.500e-06*** -2.300e-06*** -2.500e-06*** 
   (4.000e-07) (4.000e-07) (4.000e-07) (4.000e-07) 
 Life Expectancy at Birth 3.000e-07*** 3.000e-07*** 3.000e-07*** 3.000e-07*** 
   (0) (0) (0) (0) 
 Constant -.0000251*** -.0000251*** -.0000272*** -.0000272*** 
   (1.900e-06) (1.900e-06) (2.000e-06) (2.000e-06) 
 Observations 3773 3772 3697 3696 
 R-squared .1510264 .1563817 .1577045 .1632882 
Standard errors are in parentheses 
*** p<.01, ** p<.05, * p<.1  
 
      (1)   (2)   (3)   (4) 














 Health Funding per capita .0085749 .0088196 .0191244 .01945 
   (.015014) (.0148721) (.0150281) (.0148837) 
 Week 2.000e-07*** 2.000e-07*** 2.000e-07*** 2.000e-07*** 
   (0) (0) (0) (0) 
 Schools closing 1.100e-06*** 1.100e-06*** 1.000e-06*** 1.100e-06*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
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Table 4. Regression results of 2SLS regression analysis with Cases from COVID-19 per capita 
as the outcome variable and Development Funding and Health specific Funding determined 
together in the first stage. The table presents results for all countries in the world for which there 
was data on COVID-19 deaths and cases in the EU Open Data Portal dataset (1), results for all 
countries in the world for which there was data on COVID-19 deaths and cases in the EU Open 
Data Portal dataset excluding from the analysis weeks with negative records of cases from 
COVID-19 (2), results for countries in the IMF Emerging Markets and Developing Economies 
list (3) and results for countries in the IMF Emerging Markets and Developing Economies list 
excluding from the analysis weeks with negative records of cases from COVID-19 (4). 
 
Cases per capita. Development and Health funding determined together in the first stage 
 
      (1)   (2)   (3)   (4) 
 Workplace closing -4.000e-07* -4.000e-07** -5.000e-07** -5.000e-07** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Cancelation public events 3.000e-07 3.000e-07 3.000e-07 3.000e-07 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 Restrictions on gatherings 5.000e-07*** 5.000e-07*** 5.000e-07*** 5.000e-07*** 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Close public transport 1.100e-06*** 1.200e-06*** 1.200e-06*** 1.300e-06*** 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 Stay at home requirements 4.000e-07 4.000e-07 2.000e-07 2.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Restrictions on International move 2.000e-07 2.000e-07 3.000e-07 3.000e-07 
   (3.000e-07) (3.000e-07) (3.000e-07) (3.000e-07) 
 International travel controls -3.000e-07** -3.000e-07* -3.000e-07* -2.000e-07 
   (2.000e-07) (2.000e-07) (2.000e-07) (2.000e-07) 
 Public Information Campaigns -2.300e-06*** -2.400e-06*** -2.300e-06*** -2.400e-06*** 
   (4.000e-07) (4.000e-07) (4.000e-07) (4.000e-07) 
 Life Expectancy at Birth 4.000e-07*** 4.000e-07*** 4.000e-07*** 4.000e-07*** 
   (0) (0) (0) (0) 
 Constant -.0000278*** -.0000278*** -.0000305*** -.0000305*** 
   (2.100e-06) (2.100e-06) (2.100e-06) (2.100e-06) 
 Observations 3821 3820 3745 3744 
 R-squared .151115 .1561251 .157373 .1625778 
Standard errors are in parentheses 



















 Development Funding per capita .1066287*** .1067164*** .0918926*** .0918748*** 
   (.0164025) (.0164156) (.0161293) (.0161418) 
 Health Funding per capita -1.0891337* -1.0794578* -.3910457 -.3766016 
   (.5942858) (.5940538) (.5850838) (.5848415) 
 Week 9.700e-06*** 9.700e-06*** 9.900e-06*** 9.900e-06*** 
   (5.000e-07) (5.000e-07) (5.000e-07) (5.000e-07) 
 Schools closing .0000365*** .0000368*** .000035*** .0000353*** 
   (5.700e-06) (5.700e-06) (5.800e-06) (5.800e-06) 
 Workplace closing -.0000232*** -.0000234*** -.0000234*** -.0000237*** 
   (6.600e-06) (6.600e-06) (6.600e-06) (6.600e-06) 
 Cancelation public events .0000155 .000016 .0000161 .0000166* 
   (.00001) (.00001) (.00001) (.00001) 
 Restrictions on gatherings .0000189*** .0000186*** .0000182*** .0000179*** 
   (5.000e-06) (5.000e-06) (5.100e-06) (5.100e-06) 
 Close public transport .0000347*** .0000348*** .0000374*** .0000375*** 
   (7.500e-06) (7.500e-06) (7.500e-06) (7.500e-06) 
 Stay at home requirements 4.000e-07 6.000e-07 -4.900e-06 -4.800e-06 
   (6.800e-06) (6.800e-06) (6.900e-06) (6.900e-06) 
 Restrictions on International move .0000101 .00001 .0000119 .0000117 
   (8.000e-06) (8.000e-06) (8.100e-06) (8.100e-06) 
 International travel controls -3.000e-06 -3.200e-06 -5.000e-07 -7.000e-07 
   (4.400e-06) (4.400e-06) (4.400e-06) (4.400e-06) 
 Public Information Campaigns -.0000938*** -.0000936*** -.0000918*** -.0000916*** 
   (.0000119) (.0000119) (.000012) (.000012) 
 Life Expectancy at Birth 8.200e-06*** 8.200e-06*** .0000102*** .0000102*** 
   (1.200e-06) (1.200e-06) (1.300e-06) (1.300e-06) 
 Constant -.0007474*** -.0007513*** -.0008869*** -.0008916*** 
   (.000084) (.000084) (.0000851) (.0000851) 
 Observations 3678 3673 3602 3597 
 R-squared .2100268 .211028 .2284439 .2295208 
Standard errors are in parentheses 
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*** p<.01, ** p<.05, * p<.1  
 
Table 5. Regression results of 2SLS regression analysis with Cases from COVID-19 per capita 
as the outcome variable and by determining Development Funding alone in the first stage. The 
table presents results for all countries in the world for which there was data on COVID-19 deaths 
and cases in the EU Open Data Portal dataset (1), results for all countries in the world for which 
there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset excluding 
from the analysis weeks with negative records of cases from COVID-19 (2), results for countries 
in the IMF Emerging Markets and Developing Economies list (3) and results for countries in the 
IMF Emerging Markets and Developing Economies list excluding from the analysis weeks with 
negative records of cases from COVID-19 (4). 
 
Cases per capita. Development funding determined alone in the first stage 
      (1)   (2)   (3)   (4) 















 Development Funding per capita .0815058*** .0816737*** .0793981*** .0795584*** 
   (.0104477) (.0104541) (.0104189) (.0104249) 
 Week .0000102*** .0000102*** .0000104*** .0000104*** 
   (4.000e-07) (4.000e-07) (5.000e-07) (4.000e-07) 
 Schools closing .0000377*** .000038*** .0000359*** .0000362*** 
   (5.700e-06) (5.700e-06) (5.800e-06) (5.800e-06) 
 Workplace closing -.000016** -.0000162*** -.0000183*** -.0000186*** 
   (6.200e-06) (6.200e-06) (6.300e-06) (6.300e-06) 
 Cancelation public events .0000176* .0000181* .0000162* .0000166* 
   (9.700e-06) (9.800e-06) (9.800e-06) (9.800e-06) 
 Restrictions on gatherings .0000183*** .0000181*** .0000198*** .0000197*** 
   (4.500e-06) (4.500e-06) (4.600e-06) (4.600e-06) 
 Close public transport .0000317*** .0000318*** .0000332*** .0000333*** 
   (7.200e-06) (7.300e-06) (7.300e-06) (7.300e-06) 
 Stay at home requirements -5.600e-06 -5.400e-06 -.0000103 -.0000101 
   (6.700e-06) (6.700e-06) (6.800e-06) (6.800e-06) 
 Restrictions on International move 6.800e-06 6.700e-06 .0000115 .0000115 
   (7.400e-06) (7.400e-06) (7.500e-06) (7.500e-06) 
 International travel controls -2.900e-06 -3.200e-06 -5.000e-07 -8.000e-07 
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   (4.300e-06) (4.300e-06) (4.400e-06) (4.400e-06) 
 Public Information Campaigns -.0000967*** -.0000965*** -.0000954*** -.0000952*** 
   (.0000117) (.0000117) (.0000119) (.0000119) 
 Life Expectancy at Birth .0000103*** .0000104*** .0000113*** .0000113*** 
   (8.000e-07) (8.000e-07) (8.000e-07) (8.000e-07) 
 Constant -.0008939*** -.0008969*** -.0009646*** -.0009678*** 
   (.0000547) (.0000547) (.0000565) (.0000566) 
 Observations 3773 3768 3697 3692 
 R-squared .2414437 .2423368 .24975 .2506907 
Standard errors are in parentheses 
*** p<.01, ** p<.05, * p<.1  
 
Table 6. Regression results of 2SLS regression analysis with Cases from COVID-19 per capita 
as the outcome variable and by determining Health specific Funding alone in the first stage. The 
table presents results for all countries in the world for which there was data on COVID-19 deaths 
and cases in the EU Open Data Portal dataset (1), results for all countries in the world for which 
there was data on COVID-19 deaths and cases in the EU Open Data Portal dataset excluding 
from the analysis weeks with negative records of cases from COVID-19 (2), results for countries 
in the IMF Emerging Markets and Developing Economies list (3) and results for countries in the 
IMF Emerging Markets and Developing Economies list excluding from the analysis weeks with 
negative records of cases from COVID-19 (4). 
 
Cases per capita. Health funding determined alone in the first stage 
    (1) (2) (3) (4) 
    
All countries 
All countries without 
statistic anomalies 








 Health Funding per capita 1.3065337*** 1.3099952*** 1.5388425*** 1.5442118*** 
   (.4349815) (.4348426) (.4341822) (.4340328) 
 Week 9.700e-06*** 9.800e-06*** 9.900e-06*** 9.900e-06*** 
   (5.000e-07) (5.000e-07) (5.000e-07) (5.000e-07) 
 Schools closing .0000353*** .0000356*** .0000333*** .0000336*** 
   (5.900e-06) (5.900e-06) (6.000e-06) (6.000e-06) 
 Workplace closing -8.200e-06 -8.300e-06 -.0000105 -.0000107 




 Cancelation public events .0000143 .0000146 .0000137 .000014 
   (.00001) (.00001) (.0000101) (.0000101) 
 Restrictions on gatherings .0000141*** .000014*** .0000152*** .000015*** 
   (4.800e-06) (4.800e-06) (4.900e-06) (4.900e-06) 
 Close public transport .0000174** .0000175** .0000203*** .0000204*** 
   (7.600e-06) (7.700e-06) (7.700e-06) (7.700e-06) 
 Stay at home requirements 7.200e-06 7.300e-06 2.100e-06 2.200e-06 
   (6.900e-06) (6.900e-06) (7.000e-06) (7.000e-06) 
 Restrictions on International move -3.800e-06 -3.800e-06 1.500e-06 1.500e-06 
   (7.700e-06) (7.700e-06) (7.800e-06) (7.800e-06) 
 International travel controls -1.000e-06 -1.300e-06 1.000e-06 8.000e-07 
   (4.400e-06) (4.400e-06) (4.500e-06) (4.500e-06) 
 Public Information Campaigns -.0000785*** -.0000784*** -.000078*** -.0000778*** 
   (.000012) (.0000119) (.0000121) (.0000121) 
 Life Expectancy at Birth .000015*** .000015*** .0000162*** .0000162*** 
   (8.000e-07) (8.000e-07) (8.000e-07) (8.000e-07) 
 Constant -.0011635*** -.0011668*** -.0012533*** -.0012569*** 
   (.00006) (.0000601) (.0000606) (.0000606) 
 Observations 3821 3816 3745 3740 
 R-squared 
Standard errors are in parentheses 
** p<.01, ** p<.05, * p<.1  
 
.2186429 .219541 .227631 .2285632 
Standard errors are in parentheses 






Table 7. Correlations of determinants of aid with total Development Funding per capita. 











































1           




-0.0242 1          
Total 
Population 
-0.190*** -0.137*** 1         
Trade 
openness 2007 
0.435*** 0.141*** -0.190*** 1        
GDP per 
capita 2007 
0.220*** -0.274*** -0.0223 0.162*** 1       
Political 
Regime 2014 
0.321*** -0.244*** -0.0451** 0.00320 0.0440** 1      
Rule of Law 
2007 
0.433*** -0.0841*** 0.101*** 0.136*** 0.216*** 0.342*** 1     
Political 
Stability 2008 




0.381*** -0.220*** 0.171*** 0.166*** 0.332*** 0.330*** 0.868*** 0.397*** 1   
Corruption 
2008 
0.426*** -0.118*** 0.0246 0.0923*** 0.239*** 0.337*** 0.860*** 0.532*** 0.790*** 1  
Human Rights 
2007 
0.537*** 0.103*** -0.295*** 0.387*** 0.0916*** 0.308*** 0.436*** 0.724*** 0.279*** 0.504*** 1 
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Table 8. Correlations of determinants of aid with total Health Funding per capita. 
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0.312*** 1          
Total 
Population 




0.181*** 0.148*** -0.188*** 1        
GDP per 
capita 2007 
-0.148*** -0.230*** -0.0400** 0.141*** 1       
Political 
Regime 2014 
0.0711*** -0.258*** -0.0532*** -0.000108 0.164*** 1      
Rule of Law 
2007 
0.114*** -0.146*** 0.0825*** 0.109*** 0.360*** 0.371*** 1     
Political 
Stability 2008 




0.00874 -0.241*** 0.144*** 0.151*** 0.472*** 0.367*** 0.888*** 0.451*** 1   
Corruption 
2008 
0.239*** -0.195*** 0.00925 0.0590*** 0.388*** 0.366*** 0.873*** 0.559*** 0.813*** 1  
Human Rights 
2007 
0.302*** 0.0582*** -0.291*** 0.349*** 0.245*** 0.342*** 0.484*** 0.745*** 0.356*** 0.550*** 1 
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Table 9. Correlations of determinants of aid with total Development Funding per capita for 
countries on the IMF Emerging Markets and Developing Economies list. 
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-0.0374* 1          
Total 
Population 




0.439*** 0.148*** -0.197*** 1        
GDP per 
capita 2007 
0.226*** -0.265*** -0.0213 0.167*** 1       
Political 
Regime 2014 
0.315*** -0.295*** -0.0493*** -0.00381 0.0612*** 1      
Rule of Law 
2007 
0.439*** -0.0721*** 0.100*** 0.126*** 0.213*** 0.362*** 1     
Political 
Stability 2008 




0.391*** -0.202*** 0.173*** 0.157*** 0.328*** 0.361*** 0.868*** 0.412*** 1   
Corruption 
2008 
0.443*** -0.0942*** 0.0282 0.109*** 0.232*** 0.381*** 0.871*** 0.528*** 0.797*** 1  
Human Rights 
2007 
0.540*** 0.0890*** -0.296*** 0.413*** 0.0977*** 0.306*** 0.453*** 0.726*** 0.300*** 0.518*** 1 
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Table 10. Correlations of determinants of aid with total Health Funding per capita for countries 
on the IMF Emerging Markets and Developing Economies list. 
* p < 0.05, ** p < 0.01, *** p < 0.001 
Appendix B. List of Countries in Analysis and respective Country Code (Alpha 3 Code). 







Netherlands Antilles ANT 







































1           




0.302*** 1          
Total 
Population 




0.186*** 0.155*** -0.194*** 1        
GDP per 
capita 2007 
-0.144*** -0.224*** -0.0393** 0.145*** 1       
Political 
Regime 2014 
0.0553*** -0.308*** -0.0575*** -0.00679 0.180*** 1      
Rule of Law 
2007 








0.0178 -0.228*** 0.145*** 0.142*** 0.471*** 0.395*** 0.887*** 0.466*** 1   
Corruption 
2008 
0.253*** -0.178*** 0.0122 0.0731*** 0.385*** 0.405*** 0.883*** 0.556*** 0.821*** 1  
Human 
Rights 2007 












Caribbean Netherlands BES 




















Cote d'Ivoire CIV 
Cameroon CMR 




Cape Verde CPV 
Costa Rica CRI 
Cuba CUB 
Curação CUW 
Cayman Islands CYM 
Cyprus CYP 


















Falkland Islands FLK 
France FRA 
Faroe Islands FRO 
Gabon GAB 







Guinea Bissau GNB 





























Kyrgyz Republic KGZ 
Cambodia KHM 
Kiribati KIR 
Saint Kitts and Nevis KNA 







Saint Lucia LCA 
Liechtenstein LIE 












































Papua New Guinea PNG 
Poland POL 













Solomon Islands SLB 
Sierra Leone SLE 
El Salvador SLV 
San Marino SMR 
Somalia SOM 
Serbia SRB 
South Sudan SSD 
São Tome and Principe STP 
Suriname SUR 






Sint Maarten SXM 
Seychelles SYC 
Syria SYR 






East Timor TLS 









United States USA 
Uzbekistan UZB 
Vatican City VAT 
Saint Vincent and the Grenadines VCT 
Venezuela VEN 
British Virgin Islands VGB 
United States Virgin Islands VIR 
Vietnam VNM 
Vanuatu VUT 
Wallis and Fortuna WLF 
Yemen YEM 




Appendix C. List of Countries in the IMF Emerging Markets and Developing Economies. 






























Cape Verde CPV 







Costa Rica CRI 
Cote d'Ivoire CIV 
Croatia HRV 
Democratic Republic of Congo COD 
Djibouti DJI 
Dominica DMA 
Dominican Republic DOM 
East Timor TLS 
Ecuador ECU 
Egypt EGY 
El Salvador SLV 





































































Saint Kitts and Nevis KNA 
Saint Lucia LCA 
Saint Vincent and the Grenadines VCT 
São Tome and Principe STP 




Sierra Leone SLE 
Solomon Islands SLB 
Somalia SOM 
South Africa ZAF 
South Sudan SSD 

























Appendix D. The 20 countries with the higher total number of COVID-19 Cases from the 1st of 
January 2020 until the 27th of October 2020. 
Country Total Cases 
United States        8 704 524  
India        7 946 429  
Brazil        5 409 854  
Russia        1 531 224  
France        1 165 278  
Spain        1 116 738  
Argentina        1 102 288  
Colombia        1 025 052  
Mexico           895 326  
United Kingdom           894 690  
Peru           890 574  
South Africa           716 759  
Iran           574 856  
Italy           542 789  
Chile           503 598  
Iraq           455 398  
Germany           449 275  
Bangladesh           400 251  
Indonesia           392 934  
 
Appendix E. The 20 countries with the higher total number of COVID-19 Deaths from the 1st of 
January 2020 until the 27th of October 2020. 
Country Total Deaths 
United States            225 735  
Brazil            157 397  
India            119 502  
Mexico             89 171  
United Kingdom             44 998  
Italy             37 479  
Spain             35 298  
France             35 018  
Peru             34 197  
Iran             32 953  
Colombia             30 348  
Argentina             29 301  
Russia             26 269  
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South Africa             19 008  
Chile             14 003  
Indonesia             13 411  
Ecuador             12 573  
Belgium             11 059  
Iraq             10 671  
 
Appendix F. The 20 countries with the higher total disbursement of Development funding per 
capita between 2009 and 2018.  
Country 
Total Development Funding from 
2009 to 2018 (Millions USD) 
China  $                      376 100,78  
Brazil  $                      323 441,91  
Mexico  $                      208 796,75  
India  $                      190 775,98  
Turkey  $                      146 279,06  
Indonesia  $                      102 512,74  
Vietnam  $                        85 041,28  
Egypt  $                        71 699,02  
Thailand  $                        53 259,29  
Afghanistan  $                        52 390,77  
Nigeria  $                        52 367,48  
Malaysia  $                        52 346,24  
South Africa  $                        47 189,43  
Colombia  $                        46 731,66  
Syria  $                        44 817,13  
Ethiopia  $                        42 091,87  
Morocco  $                        40 095,45  
Argentina  $                        39 616,20  
Philippines  $                        37 562,80  
Iraq  $                        33 250,85  
 
Appendix G. The 20 countries with the higher total disbursement of Health specific funding per 
capita between 2009 and 2010.  
Country 
Total Health Funding from 
2009 to 2010 (Millions USD) 
Nigeria  $                            1 658,99  
India  $                            1 546,27  
Tanzania  $                            1 292,15  
Ethiopia  $                            1 264,10  
Kenya  $                            1 200,08  
South Africa  $                            1 196,81  
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Uganda  $                               884,20  
Mozambique  $                               865,64  
Democratic Republic of Congo  $                               774,11  
Pakistan  $                               751,15  
Afghanistan  $                               645,68  
Zambia  $                               611,67  
Rwanda  $                               564,97  
Bangladesh  $                               555,62  
Vietnam  $                               505,00  
China  $                               504,05  
Malawi  $                               495,16  
Ghana  $                               472,17  
Indonesia  $                               440,06  
Zimbabwe  $                               383,84  
 
 
 
 
 
 
 
 
